Form 4: Encompass Health Director Receives RSU Dividend Award
Insider Transaction Report
Encompass Health Corp. Director Terrance Williams received 28 restricted stock units on January 15, 2026, as part of a common stock dividend payment.
Summary
- Terrance Williams, a Director of Encompass Health Corp. (EHC), acquired 28 non-derivative common stock units.
- The transaction occurred on January 15, 2026, and was an award of restricted stock units (RSUs) with a transaction price of $0.
- The award was associated with a common stock dividend payment of $0.19 per share by Encompass Health on January 15, 2026.
- The closing price of Encompass Health common stock on the dividend payment date was $102.80.
- Following this transaction, Terrance Williams beneficially owns 15,169 shares of Encompass Health Common Stock directly.
- The RSUs are credited to non-employee directors' accounts in connection with common stock dividend payments, calculated based on the number of RSUs held, the per share dividend, and the closing price on the dividend payment date.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it reflects a routine, expected compensation event that aligns director interests with shareholders. It does not indicate any negative operational or financial news.
Positives
- The award of restricted stock units to a director aligns management and director interests with those of shareholders, as their compensation is tied to the company's equity performance.
- The transaction is part of a standard, pre-defined compensation plan for non-employee directors, indicating consistent corporate governance practices.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
The practice of granting restricted stock units (RSUs) to non-employee directors as part of their compensation, including dividend equivalent payments, is a common mechanism across various industries to align the interests of directors with those of long-term shareholders. This ensures that directors have a vested interest in the company's sustained performance and value creation.
Comparison to Industry Standards
- The award of restricted stock units (RSUs) to non-employee directors, with dividend equivalents, is a standard compensation practice in many publicly traded companies, including those in the healthcare sector. This method is widely adopted to incentivize long-term commitment and align director interests with shareholder value.
- While specific comparable companies or projects are not detailed in the filing, the structure of this RSU award is consistent with typical corporate governance frameworks for director compensation, which often include equity-based incentives.
Related Party Transactions
- Award of 28 restricted stock units to Terrance Williams, a non-employee director of Encompass Health Corp., as part of a dividend payment on existing RSU awards. This is a transaction between the company and a related party (director).
Stakeholder Impact
- Shareholders: The award of RSUs to a director helps align their interests with shareholders, potentially fostering decisions that enhance long-term shareholder value.
- Employees: No direct impact mentioned for general employees.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of transaction where 28 restricted stock units were awarded to Terrance Williams and Encompass Health paid a dividend of $0.19 per share. |
| 01/16/2026 | Date the Form 4 was signed by Patrick Darby, attorney-in-fact for Terrance Williams. |
Keywords
Encompass Health, EHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Dividend Reinvestment, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.